-
InDex Pharmaceuticals announces successful interactions with the PMDA for the clinical development of cobitolimod in Japan
August 16, 2022 Non Regulatory
-
InDex Pharmaceuticals gets new patent for cobitolimod granted in Europe
July 13, 2022 Regulatory
InDex Pharmaceuticals Holding AB (publ) published its interim report Q1 for January-March 2022 on May 16, 2021 at 08:00 a.m. CEST.
-
Interim Report Q2 2022
-
Presentation at Pareto Securities Healthcare Conference
-
Interim Report Q3 2022